Maria Liza Lindenberg
Papers
1
Total Citations
147
H-Index
1
About
Maria Liza Lindenberg is a leading researcher in oncologic imaging, with a primary focus on prostate cancer detection and molecular imaging. Her work centers on the development and clinical validation of novel PET/CT radiotracers, most notably ¹⁸F-FACBC (fluciclovine), to improve the localization and characterization of prostate malignancies. In her highly cited 2013 study (147 citations), she demonstrated the utility of ¹⁸F-FACBC PET/CT in differentiating localized prostate cancer from benign prostatic hyperplasia and normal tissue, comparing its performance against MR imaging and histopathologic analysis. This seminal contribution helped establish amino acid-based PET imaging as a valuable tool for intraprostatic tumor delineation, offering improved specificity over conventional methods. Her research has significantly advanced the non-invasive assessment of prostate cancer, directly impacting clinical decision-making for biopsy guidance and treatment planning. Lindenberg’s work continues to shape the integration of molecular imaging into urologic oncology, bridging the gap between radiotracer development and patient-centered diagnostic applications.
Research Focus
Key Achievements
Top Papers
- 1